Cas:945611-27-8 [C2mim][(CH3O)2PO2] manufacturer & supplier

Chemical Name:[C2mim][(CH3O)2PO2]

CAS.NO:945611-27-8

Synonyms:1-ethyl-3-methylimidazolium dimethyl phosphate;[EMIm][Me2PO4];3-methyl-1-ethylimidazol-3-ium dimethyl phosphate;[Emim][DMP];1-ethyl-3-methylimidazolium dimethylphosphate;1-ethyl-3-methyl-1H-imidazol-3-ium dimethyl phosphate

Molecular Formula:C₈H₁₇N₂O₄P

Molecular Weight:236.20500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:77.21000

Exact Mass:236.09300

LogP:1.15030

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-ethyl-3-methylimidazolium dimethyl phosphate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-ethyl-3-methyl-1H-imidazol-3-ium dimethyl phosphate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[Emim][DMP] Use and application,1-ethyl-3-methylimidazolium dimethyl phosphate technical grade,usp/ep/jp grade.

Related News: What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. [C2mim][(CH3O)2PO2] manufacturer In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. [C2mim][(CH3O)2PO2] supplier After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. [C2mim][(CH3O)2PO2] vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. [C2mim][(CH3O)2PO2] factory In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.